BACKGROUND: Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecting about 1:3,500 individuals. NF1 exon 7 displays weakly defined exon-intron boundaries, and is particularly prone to missplicing. METHODS: In this study we investigated the expression of exon 7 transcripts using bioinformatic identification of splicing regulatory sequences, and functional minigene analysis of four sequence changes [c.910C>T (R304X), c.945G>A/c.946C>A (Q315Q/L316M), c.1005T>C (N335N)] identified in exon 7 of three different NF1 patients. RESULTS: Our results detected the presence of three exonic splicing enhancers (ESEs) and one putative exonic splicing silencer (ESS) element. The wild type minigene assay resulted in three alternative isoforms, including a transcript lacking NF1 exon 7 (NF1DeltaE7). Both the wild type and the mutated constructs shared NF1DeltaE7 in addition to the complete messenger, but displayed a different ratio between the two transcripts. In the presence of R304X and Q315Q/L316M mutations, the relative proportion between the different isoforms is shifted toward the expression of NF1DeltaE7, while in the presence of N335N variant, the NF1DeltaE7 expression is abolished. CONCLUSION: In conclusion, it appears mandatory to investigate the role of each nucleotide change within the NF1 coding sequence, since a significant proportion of NF1 exon 7 mutations affects pre-mRNA splicing, by disrupting exonic splicing motifs and modifying the delicate balance between aberrantly and correctly spliced transcripts.
BACKGROUND:Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecting about 1:3,500 individuals. NF1 exon 7 displays weakly defined exon-intron boundaries, and is particularly prone to missplicing. METHODS: In this study we investigated the expression of exon 7 transcripts using bioinformatic identification of splicing regulatory sequences, and functional minigene analysis of four sequence changes [c.910C>T (R304X), c.945G>A/c.946C>A (Q315Q/L316M), c.1005T>C (N335N)] identified in exon 7 of three different NF1patients. RESULTS: Our results detected the presence of three exonic splicing enhancers (ESEs) and one putative exonic splicing silencer (ESS) element. The wild type minigene assay resulted in three alternative isoforms, including a transcript lacking NF1 exon 7 (NF1DeltaE7). Both the wild type and the mutated constructs shared NF1DeltaE7 in addition to the complete messenger, but displayed a different ratio between the two transcripts. In the presence of R304X and Q315Q/L316M mutations, the relative proportion between the different isoforms is shifted toward the expression of NF1DeltaE7, while in the presence of N335N variant, the NF1DeltaE7 expression is abolished. CONCLUSION: In conclusion, it appears mandatory to investigate the role of each nucleotide change within the NF1 coding sequence, since a significant proportion of NF1 exon 7 mutations affects pre-mRNA splicing, by disrupting exonic splicing motifs and modifying the delicate balance between aberrantly and correctly spliced transcripts.
Authors: Eva Pros; Sara Larriba; Eva López; Anna Ravella; M Lluïsa Gili; Helena Kruyer; Joan Valls; Eduard Serra; Conxi Lázaro Journal: Hum Mutat Date: 2006-11 Impact factor: 4.878
Authors: L M Messiaen; T Callens; G Mortier; D Beysen; I Vandenbroucke; N Van Roy; F Speleman; A D Paepe Journal: Hum Mutat Date: 2000 Impact factor: 4.878
Authors: Paola Origone; Alessandro De Luca; Carlo Bellini; Anna Buccino; Rita Mingarelli; Simona Costabel; Carmen La Rosa; Cecilia Garrè; Domenico A Coviello; Franco Ajmar; Bruno Dallapiccola; Eugenio Bonioli Journal: Hum Mutat Date: 2002-07 Impact factor: 4.878
Authors: Gema Garcia-Garcia; Maria J Aparisi; Teresa Jaijo; Regina Rodrigo; Ana M Leon; Almudena Avila-Fernandez; Fiona Blanco-Kelly; Sara Bernal; Rafael Navarro; Manuel Diaz-Llopis; Montserrat Baiget; Carmen Ayuso; Jose M Millan; Elena Aller Journal: Orphanet J Rare Dis Date: 2011-10-17 Impact factor: 4.123
Authors: Olatz Villate; Nekane Ibarluzea; Eugenia Fraile-Bethencourt; Alberto Valenzuela; Eladio A Velasco; Detelina Grozeva; F L Raymond; María P Botella; María-Isabel Tejada Journal: Front Genet Date: 2018-01-26 Impact factor: 4.599
Authors: Dadi Gao; Elisabetta Morini; Monica Salani; Aram J Krauson; Anil Chekuri; Neeraj Sharma; Ashok Ragavendran; Serkan Erdin; Emily M Logan; Wencheng Li; Amal Dakka; Jana Narasimhan; Xin Zhao; Nikolai Naryshkin; Christopher R Trotta; Kerstin A Effenberger; Matthew G Woll; Vijayalakshmi Gabbeta; Gary Karp; Yong Yu; Graham Johnson; William D Paquette; Garry R Cutting; Michael E Talkowski; Susan A Slaugenhaupt Journal: Nat Commun Date: 2021-06-07 Impact factor: 14.919
Authors: Gema García-García; Thomas Besnard; David Baux; Christel Vaché; Elena Aller; Sue Malcolm; Mireille Claustres; Jose M Millan; Anne-Françoise Roux Journal: Mol Vis Date: 2013-02-13 Impact factor: 2.367
Authors: María José Aparisi; Gema García-García; Elena Aller; María Dolores Sequedo; Cristina Martínez-Fernández de la Cámara; Regina Rodrigo; Miguel Armengot; Julio Cortijo; Javier Milara; Manuel Díaz-LLopis; Teresa Jaijo; José María Millán Journal: PLoS One Date: 2013-02-25 Impact factor: 3.240
Authors: Elisabete Hernández-Imaz; Yolanda Martín; Laura de Conti; German Melean; Ana Valero; Marco Baralle; Concepción Hernández-Chico Journal: PLoS One Date: 2015-10-28 Impact factor: 3.240